Intensive Medicines Monitoring Study of Toripalimab Monoclonal Injection (Tuoyi) .
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Melanoma|Lung Cance|Breast Cancer
Interventions: DRUG: Toripalimab injection
Sponsor: Shanghai Junshi Bioscience Co., Ltd.